Appointments in pharmaceutical, September 2022

Hanchata Martin formerly Biosimilar Commercial Lead and Commercial Development at Pfizer has been appointed Director, Global pipeline commercial development-Pfizer Hospital.

Brittany Buck received a promotion and has been appointed Associate Director, Trial Operations at Xenon Pharmaceuticals Inc. where she was employed as a Senior Manager, Clinical Operations.

Christopher Meile has joined GSK as Technical Associate, Pharma Tech - Greater China & Intercontinental Region in Toronto. He had formerly worked as Business Account Manager, Life Science & Technology at Amaris Consulting.

Arash Pakseresht will now occupy the functions of Associate Medical Director at Novo Nordisk in Mississauga where he had been employed as an Associate Global Medical Director.

Adam Yuck has become Director, Business Unit Head, Infectious Disease & Specialty Medicines at Merck where he had worked before as a Director, Business Unit Head, Virology (COVID-19, HIV).

Christine Castelbajac has taken up the duties of Clinical Trial Manager Level II at Syneos Health in Montreal. Previously, she had worked as Clinical Operation Manager at Merck.

Tatiana Medina has gotten the job of Global Ops Transformation and Strategy | Program Management | Lead PM at AstraZeneca in Oakville. She had been employed as a Project Director - Operations Americas Region at AstraZeneca Canada before.

Julie Nobert previously Manager, Business Partner Human Resources at AbbVie has become Manager, Total Rewards AbbVie Canada, Intercontinental.

Chirag Shah got the job as a Vice President, Pharmacetical Development at EmpowerPharm in Toronto. He formerly worked as Director at Apotex Inc. .

Vijayaraj Kulangara received a promotion and has been appointed Associate Director, Research & Development at Jubilant Radiopharma in Montreal where he had been a Senior Manager, Radiopharmaceutical Product Development Lead.